BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171002
DTEND;VALUE=DATE:20171114
DTSTAMP:20260515T113616
CREATED:20170817T065631Z
LAST-MODIFIED:20170817T082858Z
UID:2901-1506902400-1510617599@www.pharmajournalist.com
SUMMARY:Introduction to HPLC\, HPLC Troubleshooting and Method Development Online Academy
DESCRIPTION:Pharmaceutical Training International (PTI) introduces our HPLC Online Academy. \nIntroduction to HPLC\, HPLC Troubleshooting and Method Development – Online Academy\n6 week online course\, starting 2nd October\, 2017: 1.5 hours per week \nGain a complete guide to HPLC\, troubleshooting and method development from our industry expert\, Dr Mark Powell. \nAvoid the many challenges that HPLC presents\, from basic underlying concepts\, to troubleshooting problems\, to optimising the resolution. \nThe flexible learning means you have a choice of taking 3 topics\, each containing 3 hour-long modules. You may choose any one\, two\, or all three\, depending on how advanced or basic your understanding of HPLC. \n– Topic 1: Introduction to HPLC\, released on 2nd October\, 2017\n– Topic 2: HPLC Troubleshooting\, released on 16th October\, 2017\n– Topic 3: HPLC Method Development\, released on 6th November\, 2017 \nTo find out more about this course\, please visit the course website or view the full agenda here. \nThe Online Academy is a new digital\, interactive and engaging education tool designed to maximise learning for professionals with busy schedules and/or small training budgets. \nTo find out more about our online academies\, please visit our website \nAbout PTI \nPTI is a global interactive training partner committed to the personal progression of aspiring life science professionals. We have a network of expert trainers who have a minimum of 10 years’ industry experience to meet your training requirements and all our courses are CPD certified.
URL:https://www.pharmajournalist.com/event/introduction-hplc-hplc-troubleshooting-method-development-online-academy/
LOCATION:Online Course
ORGANIZER;CN="PTI Global":MAILTO:Nabihah.Durrani@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171102
DTEND;VALUE=DATE:20171104
DTSTAMP:20260515T113616
CREATED:20170810T054305Z
LAST-MODIFIED:20170810T054554Z
UID:2829-1509580800-1509753599@www.pharmajournalist.com
SUMMARY:APPCON India - ASIAN Pharma Packaging Conference
DESCRIPTION:The objective of the conference is to secure and optimize packaging by navigating regulatory requirements with innovative materials and technologies. \nKey Highlights: \n\n20+ speakers\n100+ senior packaging heads from pharma companies\n10 exhibitors\n2-days of branding opportunities through innovative formats such as technology shootout\, site visit and speaking\n\nEarly Confirmed Speakers: \n\nChief Advisor: Santanu Chowdhury\, Senior General Manager\, Packaging Development\, Sun Pharma\nBarun Kumar Dey\, Director & Head Packaging Development\, Dr Reddy’s Laboratories\nLokesh Sharma\, Director-Supply Chain\, Eisai Pharmaceuticals\nPrasad Satam\, GM Packaging Research Development\, Aurobindo Pharma\nAlpesh Shah\, General Manager-Packaging\, Intas Pharmaceuticals\nKaushik Roy\, GM – Packaging Research Development\, Mylan Laboratories\nPradeep Dhargalkar\, Head Packaging Development\, Unichem Laboratories\nAtul Mulay\, Deputy General Manager – Packaging Development\, Cadila Pharmaceuticals\nAjay Bapat\, Head Packaging Development\, Emcure Pharmaceuticals\nMunindra Roy\, Senior Manager Packaging Development\, Gland Pharma\nK Ram Mohan\, Senior Packaging\, NATCO Pharma\nRohan Aranha\, Head of Packaging R&D\, IPCA Laboratories\nSaravanan TJ\, Associate Director Quality Assurance Packaging\, Biocon\nBharat Pawar\, Drug Delivery Device And Pkg. Development\, SERUM INSTITUTE\nLalan Yadav\, Senior Manager – Asia Head\, Abbott\nSenior Representative\, Indian Institute of Packaging\, (IIP)\nBimal Mehta\, Managing Director\, Vakils Premedia\nMark Ennis\, Global Business Development Director\, Perigord\n\nTo request the Latest Agenda & more details on the Programme\, Speakers and their Presentations by email\, please contact Priyesh Waghmare \nSpecialist Content:  \n\nRegulatory Compliance Packaging\nSerialization\nTamper-Proof Packaging\nAnti-Counterfeiting Solutions\nPatient Friendly Packaging\nInnovative Materials\, Machinery and Technology\nCold Chain Packaging\nAutomation Packaging\n\nWe are now open for number of speaking\, sponsorship\, exhibiting and advertisement opportunities available for companies who wish to communicate their product and service offering to above elite group. We have some special and attractive sponsorship packages made exclusively for you. \nKey advantages of partnering with us: \n\nPositionyourself as a thought leader in the industry\nDelivera product presentation in the networking area\nShowcaseyour products and services in the exhibition area\nAdvertiseyour solutions in the on-site delegate booklet\nDistributeyour literature to all the attendees\nBrandyour company on our conference materials\n\nPrevious Singapore Edition Attendees Included: \nAbbott Manufacturing Singapore\, Amcor\, Apex Pharma Marketing Pte Ltd\, ARQon Pte Ltd\, Astellas Pharma Singapore Pte. Ltd\,Avery Dennison Singapore (Pte) Ltd\, Beacons Pharmaceuticals Pte Ltd\, Constantia Flexibles International GmbH\, Dätwyler Sealing Solutions\, DKSH Singapore Pte Ltd\, Dnahc Cambodia\, Dr Reddy’s Laboratories\, Ekberg Emballage AB\, Esko Graphics\, European Chamber of Commerce (Singapore)\, General Mills\, GlaxoSmithKline Consumer Healthcare\, Goldplus Universal Pte Ltd\,HGP Asia Pte\, ICM Pharma Pte. Ltd.\, Agency for Science Technology and Research (A*STAR)\, Klöckner Pentaplast\, LF Asia Distribution\, Medicell Pharmaceutical (S) Pte. Ltd\, Mundipharma\, MVK Meditech\, National Environment Agency\, Nicosia Creative Espresso Pte Ltd\, Opto-Pharm Pte Ltd\, Orient Design\, Parexel International Pvt Ltd\, Pharma Pharmaceutical Industries\, PT Bayer Indonesia\, PT Graha Farma\,PT Kalbe Farma\, PT Kino Indonesia\, PT. Galenium Pharmasia Laboratories\, RVK Meditech\, Sanofi\, SICPA\, SPA Governing Board\, Sun Pharma\, Tesa Scribos GmbH\, Teva Pharmaceutical\, ThePackHub\, Uhlmann Singapore LLP\,UPM Raflatac\, Versalis Spa\, BOBST\, Softbox Systems\, SHL Group and many more… \nEvent Website: http://www.wplgroup.com/aci/event/pharma-packaging-india/ \nQuote discount code: \nPPCi1MP20 to claim for 20% discount expiring 7th September 2017 & \nPPCi1MP15 to claim for 15% discount expiring 19th October 2017
URL:https://www.pharmajournalist.com/event/appcon-india-asian-pharma-packaging-conference/
LOCATION:Mumbai-India
ORGANIZER;CN="Active Communications International (ACI)":MAILTO:pwaghmare@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171115
DTEND;VALUE=DATE:20171117
DTSTAMP:20260515T113616
CREATED:20170628T035014Z
LAST-MODIFIED:20170628T035419Z
UID:2414-1510704000-1510876799@www.pharmajournalist.com
SUMMARY:4th annual Biosimilars North America
DESCRIPTION:Building on the success of previous events\, SMi has announced the return of its 4th annual Biosimilars North America Conference\, taking place on November 15 and 16\, 2017 in Iselin\, New Jersey. \nThe market for biosimilars in North America continues to grow and has become highly lucrative. As such\, pharmaceutical companies continue to find ways to differentiate their products in such an emerging market. Thus\, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development\, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements. \nThis year\, the conference will also explore significant developmental topics within the sector including the impact of FDA’s newly implemented biosimilar interchangeability guidelines\, the US market access landscape\, and biosimilars of orphan drugs. \nKey highlights this year will include \n\na presentation from Sandoz on the FDA issuing the long-awaited biosimilar interchangeability guidance;\na session on complex biosimilars and new technologies from MedImmune;\nstrategies to combat legal\, policy and commercial obstacles to development and launch;\ninsights on latest development strategies and market access from Fujifilm Diosynth Biotechnologies;\ncase studies on drug product and formulation development considerations; and\nImplications of the landmark ruling of the Amgen v Sandoz case\n\nKey speakers include \n\nRichard DiCicco\, Chairman\, Harvest Moon Pharmaceuticals Inc\nCindy Cao\, Executive Director & Head of US Regulatory Affairs fo Biopharmaceuticals\, Sandoz\nT. Shantha Raju\, Senior Director\, MedImmune\nChrys Kokino\, Head Global Biologics Commercial\, Mylan\nSteinar Madsen\, Medical Director\, Norwegian Medicines Agency\nBruce Leicher\, Senior Vice President and General Counsel\, Momenta Pharmaceuticals\, Inc\nHiten Gutka\, Principal Scientist Formulation Development – Biosimilar Development\, Oncobiologics Inc\nPatrick Robertson\, Director\, Program Design\, FUJIFIlM Diosynth Biotechnologies\n\nThe full roster of speakers and their topics can be found on www.biosimilars-northamerica.com/pharmajournalist \nRegistration is now live on the event website and there For more information visit: www.biosimilars-northamerica.com/pharmajournalist
URL:https://www.pharmajournalist.com/event/4th-annual-biosimilars-north-america/
LOCATION:Renaissance Woodbridge Hotel\, Iselin\, New Jersey\, USA
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171116
DTEND;VALUE=DATE:20171118
DTSTAMP:20260515T113616
CREATED:20171018T002540Z
LAST-MODIFIED:20190521T093633Z
UID:3476-1510790400-1510963199@www.pharmajournalist.com
SUMMARY:Lyophilization USA
DESCRIPTION:Following its successful second year\, SMi Group announces the return of its 3rd annual Lyophilization USA Conference to New Jersey\, this November 2017. \n \nAs biopharmaceuticals continue to dominate the market\, the need for greater shelf life and protein stability\, has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing. \nOne of the main challenges in pharmaceutical lyophilization\, continues to be the scale- up and the implementation of QbD protocols for the optimization of cycles. Several companies are researching and developing ways to facilitate commercial bulk lyophilization of vaccines\, protein and cells while also reducing costs. \nLyophilization USA will gather leading experts from top pharma companies to discuss the latest cutting edge developments in freeze drying\, as well as solutions to on-going industry challenges. \nKey Topics Addressed: \n– The impact of controlled nucleation on product quality and the technology being used for controlled ice         nucleation.\n– Examining the development and scale up of a freeze-drying cycle for biotherapeutics.\n– Highlighting the approaches to effective holistic packaging and innovative design. \nFeatured Speakers: \n– Lokesh Kumar\, Associated Scientist\, Genentech\n– Charlie Tang\, Associate Director\, Formulation Development\, Regeneron Pharmaceuticals\n– Guido Schmitz\, Global Head of Packaging & Technology Innovation\, Bayer Consumer Care\n– Perceval Sondag\, Principal Statistician\, Arlenda\n– Eric Munson\, Professor\, Pharmaceutical Sciences\, University of Kentucky\n– Kelly Forney Stevens\, Drug Product Development\, GSK Vaccines\n– Melissa Lash\, Scientist\, Large Molecule Drug Development\, Johnson & Johnson \nView the preliminary agenda here: www.lyophilization-usa.com/pj
URL:https://www.pharmajournalist.com/event/lyophilization-usa/
LOCATION:Iselin\, New Jersey
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171128
DTEND;VALUE=DATE:20171130
DTSTAMP:20260515T113616
CREATED:20170829T093920Z
LAST-MODIFIED:20170829T094210Z
UID:2969-1511827200-1511999999@www.pharmajournalist.com
SUMMARY:Pharma and Device Packaging and Labeling West Coast 2017
DESCRIPTION:Following a very successful launch year\, we are thrilled to announce that Pharma and Device Packaging and Labeling will be returning to the West Coast for our 2nd annual event. \nBringing together those involved in packaging\, labeling and supply chain in both pharmaceutical and medical device companies\, this event offers you the only chance to discuss\, deliberate and debate the pressing issues for the industry. With varied subjects covered from Core Data Sheet to UDI\, packaging innovation to artwork management and everything in between\, our 2017 show promises to bring you even more relevant and divisive content. \n\nA look back at our inaugural 2016 event… \nIn 2016 we launched our successful Pharma Packaging and Labeling USA event in San Francisco\, after many successful ongoing years in Philadelphia. Bringing together both the pharmaceutical and medical device industries in the area\, our agenda focused on the commercial packaging and labeling challenges and innovations shaking up the industry now and in the future.
URL:https://www.pharmajournalist.com/event/pharma-device-packaging-labeling-west-coast-2017/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171128
DTEND;VALUE=DATE:20171130
DTSTAMP:20260515T113616
CREATED:20171018T003307Z
LAST-MODIFIED:20171018T003542Z
UID:3481-1511827200-1511999999@www.pharmajournalist.com
SUMMARY:Ophthalmic Drugs
DESCRIPTION:SMi Group are thrilled to announce the launch of the Ophthalmic Drugs Conference\, being held on the 28-29 November 2017 at the Copthorne Tara Hotel in London\, UK. \n \nOcular disease therapy has seen a surge in innovation in areas ranging from glaucoma to macular degeneration and diabetic retinopathy. As ageing populations grow globally the need for treatment in this field has grown and is expected to reach a figure of $21 billion by the year 2022. – (Source: Business Wire –http://bit.ly/2rlECrh) \nOphthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment\, ocular medical devices\, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials\, to deepen your understanding of inherited ocular diseases. \n‘By far the most important organs of sense are our eyes. We perceive up to 80 per cent of all impressions by means of our sight. And if other senses such as taste or smell stop working\, it’s the eyes that best protect us from danger.’ – (Source: Zeiss –http://bit.ly/2tl5iua) \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \n– Naj Sharif\, Executive Director in R&D\, Head\, Global Alliances & External Research\, Santen Inc\n– Mitchell de Long\, Vice President\, Chemistry\, Aerie Pharmaceuticals\n– Michael Lai\, Global Program Medical Director\, Novartis\n– Sérgio Leal\, Ophthalmologist Director\, Global Clinical Leader\, Bayer\n– Victor Chong\, Global Head of Ophthalmology\, Boehringer Ingelheim\n– Amir Shojaei\, Vice President Therapeutic Area Head\, Ophthalmology\, Shire\n– Tomas Navratil\, Senior Vice President\, Development\, Envisia Therapeutics \nVisit the website for the full speaker line-up: www.ophthalmicdrugs.com/pj \nSome of the featured highlights will include: \n– New approaches to drug delivery to the back of the eye and nanotechnology\n– Discover innovation in diagnostic technology\n– Regulatory keynote on medical devices and human factors\n– Explore various combination products improving health outcomes\n– Exciting insight into stem cell and gene therapy \nView the full agenda: www.ophthalmicdrugs.com/pj
URL:https://www.pharmajournalist.com/event/ophthalmic-drugs/
LOCATION:London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171129
DTEND;VALUE=DATE:20171201
DTSTAMP:20260515T113616
CREATED:20170718T041426Z
LAST-MODIFIED:20170718T041608Z
UID:2519-1511913600-1512086399@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2017
DESCRIPTION:Clinical Trial Supply Southern California returns for another year to La Jolla\, San Diego. Once again it promises to deliver some of the most cutting edge content in the world of Clinical Trial Supplies.\n \nStandout speakers for 2017 include those from Ionis\, Intercept and Acadia\, but the event also featured some innovative biotech companies from the local area Valley Fever Solutions and Prometheus Laboratories. \nFor more information visit – http://www.arena-international.com/ctssocal
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2017/
LOCATION:La Jolla\, San Diego (Venue TBC)
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
END:VCALENDAR